Evaluation of "C'Est La Vie!" Digital Health Education

June 4, 2026 updated by: Philip Massey, PhD, MPH, FAAHB, University of California, Los Angeles

C'Est la Vie: Measurement, Learning, and Evaluation

The University of California, Los Angeles (UCLA) will lead the online evaluation of four digital health campaigns developed by a non-governmental organization (NGO), Réseau Africain de l'Éducation pour la Santé (RAES), or African Network for Health Education in English, from West Africa and delivered via social media. The full evaluation study will begin enrolling participants in Fall 2023 and will conclude in Winter 2026. Approximately 3,000 participants will be recruited for each of the four campaigns (n=12,000), and each campaign will last approximately 2 months. The four campaigns are scheduled to take place in Fall 2023, Winter 2025, Fall 2025, and Winter 2026, corresponding to evaluation activities including baseline and follow-up data collection.

The scope of work for UCLA will center around evaluation activities related to program activities developed and implemented by the non-governmental organization. The digital and online programming will be developed and implemented by the non-governmental organization with the goal of strengthening sexual and reproductive health among young people in Senegal, Burkina Faso, and Cote d'Ivoire. UCLA will lead the evaluation, examining if health education programming contributes to this goal by developing and implementing an evaluation design for digital and online programming.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
492

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Burkina Faso
      • Ouagadougou, Burkina Faso
        • ONG RAES Facebook Account
  • Côte d’Ivoire
      • Abidjan, Côte d’Ivoire
        • ONG RAES Facebook Account
  • Senegal
      • Dakar, Senegal
        • ONG RAES Facebook Account

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Between the ages of 15-24 years, residing in Burkina Faso, Côte d'Ivoire, or Senegal, having a verifiable Facebook account, having access to the internet, and speak French.

Exclusion Criteria:

  • No meeting inclusion criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Peer role model educator
Trained young people to serve as online peer influencers to the participants. The online peer influencers were young people who would be considered peers or contemporaries of the study participants, similar in age, gender, and country. Similar to the online marketers, the online peer influencers were trained by RAES to ensure the information shared through their personal experiences was correct and accurate as it related to the content themes of preventing early pregnancy, contraceptive knowledge and use, community norms, and services. Study participants did not know the peer influencers personally.
Behavioral: Evaluating how to deliver messages to young people online
Study content for the 2-week Facebook-based intervention was developed by West African non-governmental organization, Réseau Africain de l'Éducation pour la Santé (RAES), or African Network for Health Education in English. RAES created culturally relevant SRH information tailored to the target population of young adults, taking the form of educational materials and personal stories and building off of their social communication campaign that promotes health and social change, entitled C'est la Vie! (CLV). Content themes centered around preventing early pregnancy, contraceptive knowledge and use, community norms pertaining to sexual and reproductive health, and available online services. All content was in French.
Experimental: Marketing influencer educator
Marketing influencers were individuals who had a network of followers on social media and were regarded as digital opinion leaders with significant social influence on their network of followers. We trained these influencers and worked closely with them to develop and share SRH information that highlighted the content themes of preventing early pregnancy, contraceptive knowledge and use, community norms, and available online services.
Behavioral: Evaluating how to deliver messages to young people online
Study content for the 2-week Facebook-based intervention was developed by West African non-governmental organization, Réseau Africain de l'Éducation pour la Santé (RAES), or African Network for Health Education in English. RAES created culturally relevant SRH information tailored to the target population of young adults, taking the form of educational materials and personal stories and building off of their social communication campaign that promotes health and social change, entitled C'est la Vie! (CLV). Content themes centered around preventing early pregnancy, contraceptive knowledge and use, community norms pertaining to sexual and reproductive health, and available online services. All content was in French.
Experimental: Role model and marketing influencer
Combined health education content from the peer role model arm and the marketing influencer arm.
Behavioral: Evaluating how to deliver messages to young people online
Study content for the 2-week Facebook-based intervention was developed by West African non-governmental organization, Réseau Africain de l'Éducation pour la Santé (RAES), or African Network for Health Education in English. RAES created culturally relevant SRH information tailored to the target population of young adults, taking the form of educational materials and personal stories and building off of their social communication campaign that promotes health and social change, entitled C'est la Vie! (CLV). Content themes centered around preventing early pregnancy, contraceptive knowledge and use, community norms pertaining to sexual and reproductive health, and available online services. All content was in French.
Active Comparator: Standard content
The comparison group, standard SRH information was shared with participants, serving as a comparison (i.e., the typical information that is shared online).
Behavioral: Evaluating how to deliver messages to young people online
Study content for the 2-week Facebook-based intervention was developed by West African non-governmental organization, Réseau Africain de l'Éducation pour la Santé (RAES), or African Network for Health Education in English. RAES created culturally relevant SRH information tailored to the target population of young adults, taking the form of educational materials and personal stories and building off of their social communication campaign that promotes health and social change, entitled C'est la Vie! (CLV). Content themes centered around preventing early pregnancy, contraceptive knowledge and use, community norms pertaining to sexual and reproductive health, and available online services. All content was in French.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Self-reported 12-item knowledge scale
Time Frame: From enrollment to follow-up assessment after 2-week intervention.
A 12-item knowledge score taken from the Phase 8 version of the Demographic and Health Surveys Program woman's questionnaire. Participants answer Yes or No to if they know 12 common contraceptive methods. Scores range from 0-12 with 12 indicating higher knowledge.
From enrollment to follow-up assessment after 2-week intervention.
Self-reported 3-item self-efficacy scale
Time Frame: From enrollment to follow-up assessment after 2-week intervention.
3 item scale adapted from the Contraceptive Self-Efficacy among women in sub-Saharan Africa (CSESSA), a scale found to be reliable among population samples in sub-Saharan Africa. Scales range from 0 (not at all confident) to 10 (completely confident).
From enrollment to follow-up assessment after 2-week intervention.
Self-reported 3-item awareness scale of online services.
Time Frame: From enrollment to the end of the 2-week intervention
3-item scale. Participants are asked if they are aware of three specific providers that provide online services throughout West African mentioned in the study content. Scores ranged from 0 (unaware of any service providers) to 3 (aware of all three service providers).
From enrollment to the end of the 2-week intervention
Self-reported 6-item use of online services scale.
Time Frame: From enrollment to follow-up assessment after 2-week intervention.
6-item scale. Participants are asked to self-report if they used any of six online services that were highlighted in the study content, including using websites for advice, using a chat-bot, and communicating with organizations through WhatsApp. Scores range from 0 (no services used) to 6 (six services used).
From enrollment to follow-up assessment after 2-week intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of California, Los Angeles

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 1, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 15, 2026

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 31, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 1, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 4, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 9, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 9, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 4, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • UCLA IRB-23-0752

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The datasets analyzed during the current study are available from the corresponding author upon reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Education

Clinical Trials on Evaluating how to deliver messages to young people online

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings